Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 1, pp. 155-179
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 133
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 107
Research Progress on Regulation of Immune Response by Tanshinones and Salvianolic Acids of Danshen (Salvia miltiorrhiza Bunge)
Jiawen Tang, Xueying Zhao
Molecules (2024) Vol. 29, Iss. 6, pp. 1201-1201
Open Access | Times Cited: 11
Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents
Hidayat Hussain, Iftikhar Ali, Daijie Wang, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 12, pp. 1497-1516
Open Access | Times Cited: 45
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 35
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions
Mahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Cellular Signalling (2022) Vol. 94, pp. 110323-110323
Closed Access | Times Cited: 29
Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action
Rosaria Acquaviva, Giuseppe Antonio Malfa, Monica Rosa Loizzo, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4791-4791
Open Access | Times Cited: 29
Phytochemicals and their Nanoformulations for Overcoming Drug Resistance in Head and Neck Squamous Cell Carcinoma
Zhai Pingping, Nan Chen, Yong Tang
Pharmaceutical Research (2025)
Closed Access
Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway
Danning Shi, Hongbo Li, Zeye Zhang, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262389-e0262389
Open Access | Times Cited: 18
Insights Into the Properties, Biological Functions, and Regulation of USP21
Tao An, Yanting Lu, Yan Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Molecular Mechanism of Tanshinone against Prostate Cancer
Wěi Li, Tao Huang, Shenghan Xu, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5594-5594
Open Access | Times Cited: 14
Skin microbiome reconstruction and lipid metabolism profile alteration reveal the treatment mechanism of Cryptotanshinone in the acne rat
Zhaoming Zhu, Quanfu Zeng, Zhuxian Wang, et al.
Phytomedicine (2022) Vol. 101, pp. 154101-154101
Closed Access | Times Cited: 13
Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability
Zhao Wen-zheng, Bohao Ruan, Xiaoyi Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Cryptotanshinone interferes with chondrocyte apoptosis in osteoarthritis by inhibiting the expression of miR‑574‑5p
Song-tao Yue, Xiaochuan Su, Junyan Teng, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 15
Integrated Proteomics and Metabolomics Link Acne to the Action Mechanisms of Cryptotanshinone Intervention
Zhaoming Zhu, Tingting Chen, Zhuxian Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Salviolone from Salvia miltiorrhiza Roots Impairs Cell Cycle Progression, Colony Formation, and Metalloproteinase-2 Activity in A375 Melanoma Cells: Involvement of P21(Cip1/Waf1) Expression and STAT3 Phosphorylation
Valentina Zanrè, Rachele Campagnari, Antonietta Cerulli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1121-1121
Open Access | Times Cited: 9
Cryptotanshinone Inhibits Bladder Cancer Cell Malignant Progression in a Lipopolysaccharide-Induced Inflammatory Microenvironment through NLRP3 Inhibition
Chenye Tang, Xiao Guo, Yu Li, et al.
Mediators of Inflammation (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 1
Cryptotanshinone-Induced Permeabilization of Model Phospholipid Membranes: A Biophysical Study
Julia Ortiz, Francisco J. Aranda, José A. Teruel, et al.
Membranes (2024) Vol. 14, Iss. 6, pp. 118-118
Open Access | Times Cited: 1
Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications
Ziyao Zheng, Liyuan Ke, Silin Ye, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 6031-6060
Open Access | Times Cited: 1
Drug monomers from Salvia miltiorrhiza Bge. promoting tight junction protein expression for therapeutic effects on lung cancer
Guanghui Zhu, Daorui Li, Xueqian Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer
Pan-Quan Luo, Li-Xiang Zhang, Zhangming Chen, et al.
Cell Cycle (2023) Vol. 22, Iss. 12, pp. 1463-1477
Open Access | Times Cited: 3
Oral Administration of Cryptotanshinone-Encapsulated Nanoparticles for the Amelioration of Ulcerative Colitis
Li Zhang, Longfei Yu, Yueguang Wei
Cellular and Molecular Bioengineering (2021) Vol. 15, Iss. 1, pp. 129-136
Open Access | Times Cited: 8
Comparative Proteomics Analysis Reveals the Reversal Effect of Cryptotanshinone on Gefitinib-Resistant Cells in Epidermal Growth Factor Receptor-Mutant Lung Cancer
Peiheng Cai, Gaofan Sheng, Shiqin Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Prospective pharmacological potential of cryptotanshinone in cancer therapy
Ashif Ahamed, Mahmadul Hasan, Arijit Samanta, et al.
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 9, pp. 100308-100308
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top